Skelettmetastasen der Extremitäten – Management und operative Behandlungskonzepte

Zusammenfassung

Aufgrund der steigenden Anzahl an Tumorerkrankungen in Deutschland sowie der verlängerten Lebensdauer mit einer malignen Erkrankung sind Folgeerscheinungen wie Skelettmetastasen und pathologische Frakturen eine zunehmende klinische Herausforderung. Dieser Artikel stellt die Stufendiagnostik sowie die Behandlungsmöglichkeiten bei Patienten mit Skelettmetastasen der Extremitäten vor.

• Literatur

• 1 Robert-Koch-Institut. Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V. Krebs in Deutschland 2011/2012. 10.. Aufl. Berlin: Robert-Koch-Institut; 2015
• 2 Robert-Koch-Institut. Zentrum für Krebsregisterdaten. Im Internet: https://www.krebsdaten.de/Krebs/DE/Home/homepage_node.html ; Stand: 17.12.2017
• 3 Coleman RE. Skeletal complications of malignancy. Cancer 1997; 80: 1588-1594
• 4 Ashford RU, Benjamin L, Pendlebury S. et al. The modern surgical and non-surgical management of appendicular skeletal metastases. Orthopaedics and Trauma 2012; 26: 184-199
• 5 Kufe DW, Pollock RE, Weichselbaum RR. et al. Holland-Frei Cancer Medicine. 6th . ed. Hamilton, Ont., Lewiston, NY: BC Decker; 2003
• 6 Cancer ResearchUK. Cancer Statistics for the UK (2017). Im Internet: https://www.cancerresearchuk.org/#/ ; Stand: 17.12.2017
• 7 American Cancer Society. Cancer stat facts (Juni 2017). Im Internet: https://seer.cancer.gov/statfacts/html/all.html ; Stand 17.12.2017
• 8 Yang HL, Liu T, Wang XM. et al. Diagnosis of bonemetastases: a meta-analysis comparing 18 FDG PET, CT, MRI and bone scintigraphy. Eur Radiol 2011; 21: 2604-2617
• 9 Mitsuyoshi G, Naito N, Kawai A. et al. Accurate diagnosis of musculoskeletal lesions by core needle biopsy. J Surg Oncol 2006; 94: 21-27
• 10 Mankin HJ, Lange TA, Spanier SS. The classic: the hazards of biopsy in patients with malignant primary bone and soft-tissue tumors. Clin Orthop Relat Res 2006; (450) 4-10
• 11 Katagiri H, Okada R, Takagi T. et al. New prognostic factors and scoring system for patients with skeletal metastasis. Cancer Med 2014; 3: 1359-1367
• 12 Oken MM, Creech RH, Tormey DC. et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Amn J Clin Oncol 1982; 5: 649-656
• 13 Mirels H. Metastatic disease in long bones: A proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop Relat Res 1989; (249) 256-264
• 14 Ruggieri P, Mavrogenis AF, Casadei R. et al. Protocol of surgical treatment of long bone pathological fractures. Injury 2010; 41: 1161-1167
• 15 Capanna R, Campanacci DA. The treatment of metastases in the appendicular skeleton. J Bone Joint Surg Br 2001; 83: 471-481
• 16 Wedin R, Bauer HC, Wersäll P. Failures after operation for skeletal metastatic lesions of long bones. Clin Orthop Relat Res 1999; (358) 128-139
• 17 Schwabe P, Ruppert M, Tsitsilonis S. et al. Surgical management and outcome of skeletal metastatic disease of the humerus. Acta Chir Orthop Traumatol Cech 2014; 81: 365-370
• 18 Maerdian S, Schaser KD, Ruppert M. et al. Skeletal Metastatic Disease of the Femur: Results by Management with Intramedullary Nailing. Acta Chir Orthop Traumatol Cech 2015; 82: 192-197
• 19 Piccioli A, Maccauro G, Rossi B. et al. Surgical treatment of pathologic fractures of humerus. Injury 2010; 41: 1112-1116
• 20 Pape A, Hofbauer C, Kleber C. et al. Der Stellenwert der klassischen Verbundosteosynthese langer Röhrenknochen und des Beckens. OP Journal 2017; 33: 11-17
• 21 Wedin R, Hansen BH, Laitinen M. et al. Complications and survival after surgical treatment of 214 metastatic lesions of the humerus. J Shoulder Elbow Surg 2012; 21: 1049-1055
• 22 Scotti C, Camnasio F, Peretti GM. et al. Modular prostheses in the treatment of proximal humerus metastases: review of 40 cases. J Orthopaed Traumatol 2008; 9: 5-10
• 23 Gregory JJ, Ockendon M, Cribb GL. et al. The outcome of locking plate fixation for the treatment of periarticularmetastases. Acta Orthop Belg 2011; 77: 362-370
• 24 Piccioli A, Rossi B, Scaramuzzo L. et al. Intramedullary nailing for treatment of pathologic femoral fractures due to metastases. Injury 2014; 45: 412-417
• 25 Afshar A, Farhadnia P, Khalkhali H. Metastases to the hand and wrist: an analysis of 221 cases. J Hand Surg Am 2014; 39: 923-932.e17
• 26 Schaser KD, Melcher I, Märdian S. et al. Komplikationsmanagement nach Resektion und Defektrekonstruktion hüftgelenknaher Tumoren. Orthopäde 2014; 43: 92-102
• 27 Weber KL, O'Connor MI. Operative Treatment of Long Bone Metastases. Clin Orthop Related Res 2003; 415: 276-278
• 28 Nilsson J, Gustafson P. Surgery for metastatic lesions of the femur: good outcome after 245 operations in 216 patients. Injury 2008; 39: 404-410
• 29 Bauer HCF. Controversies in the surgical management of skeletal metastases. J Bone Joint Surg Br 2005; 87: 608-617
• 30 Kelly CM, Wilkins RM, Eckardt JJ. et al. Treatment of metastatic disease of the tibia. Clin Orthop Relat Res 2003; (415) 219-229
• 31 Bryson DJ, Wicks L, Ashford RU. The investigation and management of suspected malignant pathological fractures: a review for the general orthopaedic surgeon. Injury 2015; 46: 1891-1899
• 32 Evans S, Ramasamy A, Jeys L. et al. Delayed diagnosis in metastatic lesions of the foot. Ann R Coll Surg Engl 2014; 96: 536-538
• 33 Ruggieri P, Mavrogenis AF, Casadei R. et al. Review of Foot Tumors Seen in a University Tumor Institute. J Foot Ankle Surg 2014; 53: 282-285